The Efficacy of Empagliflozin in Combination with Pioglitazone on the Improvement of Fatty Liver Disease in Patients with Type 2 Diabetes
Author | Morteza Aghajanpoor | en |
Author | Mehrzad Gholampourdehaki | en |
Author | Reza Mosaed | en |
Author | Iraj Mirzaii-Dizgah | en |
Author | Afsaneh Vosughi | en |
Orcid | Mehrzad Gholampourdehaki [0000-0001-8381-5122] | en |
Orcid | Iraj Mirzaii-Dizgah [0000-0002-0050-4191] | en |
Issued Date | 2024-06-30 | en |
Abstract | Background | en |
DOI | https://doi.org/10.5812/amh-144009 | en |
Keyword | Empagliflozin | en |
Keyword | Pioglitazone | en |
Keyword | Non-alcoholic Fatty Liver Disease | en |
Keyword | Diabetes Mellitus | en |
Publisher | Brieflands | en |
Title | The Efficacy of Empagliflozin in Combination with Pioglitazone on the Improvement of Fatty Liver Disease in Patients with Type 2 Diabetes | en |
Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- amhsr-22-2-144009-publish-pdf.pdf
- Size:
- 117.25 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF